Comments
Loading...

Haemonetics

HAENYSE
Logo brought to you by Benzinga Data
$75.61
-0.93-1.22%
At Close: -
$75.61
00.00%
After Hours: 5:06 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$125.00
Lowest Price Target1
$60.00
Consensus Price Target1
$101.27

Haemonetics (NYSE:HAE) Stock, Analyst Ratings, Price Targets, Forecasts

Haemonetics Corp has a consensus price target of $101.27 based on the ratings of 11 analysts. The high is $125 issued by JMP Securities on August 13, 2024. The low is $60 issued by Morgan Stanley on January 7, 2022. The 3 most-recent analyst ratings were released by CL King, B of A Securities, and BTIG on September 13, 2024, September 11, 2024, and September 10, 2024, respectively. With an average price target of $104.33 between CL King, B of A Securities, and BTIG, there's an implied 37.99% upside for Haemonetics Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
1
May
0
0
0
0
Jun
1
1
Aug
1
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.3
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

CL King
B of A Securities
BTIG
Citigroup
JMP Securities

1calculated from analyst ratings

Analyst Ratings for Haemonetics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Haemonetics (HAE) stock?

A

The latest price target for Haemonetics (NYSE:HAE) was reported by CL King on September 13, 2024. The analyst firm set a price target for $116.00 expecting HAE to rise to within 12 months (a possible 53.42% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Haemonetics (HAE)?

A

The latest analyst rating for Haemonetics (NYSE:HAE) was provided by CL King, and Haemonetics initiated their buy rating.

Q

When was the last upgrade for Haemonetics (HAE)?

A

The last upgrade for Haemonetics Corp happened on June 12, 2024 when Needham raised their price target to $112. Needham previously had a hold for Haemonetics Corp.

Q

When was the last downgrade for Haemonetics (HAE)?

A

The last downgrade for Haemonetics Corp happened on January 27, 2022 when Needham changed their price target from N/A to N/A for Haemonetics Corp.

Q

When is the next analyst rating going to be posted or updated for Haemonetics (HAE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Haemonetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Haemonetics was filed on September 13, 2024 so you should expect the next rating to be made available sometime around September 13, 2025.

Q

Is the Analyst Rating Haemonetics (HAE) correct?

A

While ratings are subjective and will change, the latest Haemonetics (HAE) rating was a initiated with a price target of $0.00 to $116.00. The current price Haemonetics (HAE) is trading at is $75.61, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch